BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25015368)

  • 1. A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol.
    Thomas N; Shawyer F; Castle DJ; Copolov D; Hayes SC; Farhall J
    BMC Psychiatry; 2014 Jul; 14():198. PubMed ID: 25015368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance and commitment therapy for psychosis: randomised controlled trial.
    Shawyer F; Farhall J; Thomas N; Hayes SC; Gallop R; Copolov D; Castle DJ
    Br J Psychiatry; 2017 Feb; 210(2):140-148. PubMed ID: 27979820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.
    Reininghaus U; Klippel A; Steinhart H; Vaessen T; van Nierop M; Viechtbauer W; Batink T; Kasanova Z; van Aubel E; van Winkel R; Marcelis M; van Amelsvoort T; van der Gaag M; de Haan L; Myin-Germeys I
    Trials; 2019 Dec; 20(1):769. PubMed ID: 31878966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial.
    Freeman D; Emsley R; Diamond R; Collett N; Bold E; Chadwick E; Isham L; Bird JC; Edwards D; Kingdon D; Fitzpatrick R; Kabir T; Waite F;
    Lancet Psychiatry; 2021 Aug; 8(8):696-707. PubMed ID: 34246324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders.
    Shawyer F; Farhall J; Mackinnon A; Trauer T; Sims E; Ratcliff K; Larner C; Thomas N; Castle D; Mullen P; Copolov D
    Behav Res Ther; 2012 Feb; 50(2):110-21. PubMed ID: 22186135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing ACT: evaluating the effectiveness of psychoeducation and Acceptance and Commitment Therapy (ACT) groups for people with bipolar disorder: study protocol for pilot randomised controlled trial.
    O'Donoghue E; Clark A; Richardson M; Hodsoll J; Nandha S; Morris E; Kane F; O'Keeffe D; Butler L; Jolley S
    Trials; 2018 Aug; 19(1):436. PubMed ID: 30103785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance and commitment therapy for older people with treatment-resistant generalised anxiety disorder: the FACTOID feasibility study.
    Gould RL; Wetherell JL; Serfaty MA; Kimona K; Lawrence V; Jones R; Livingston G; Wilkinson P; Walters K; Novere ML; Howard RJ
    Health Technol Assess; 2021 Sep; 25(54):1-150. PubMed ID: 34542399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
    Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
    Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trial.
    Peters E; Hardy A; Dudley R; Varese F; Greenwood K; Steel C; Emsley R; Keen N; Bowe S; Swan S; Underwood R; Longden E; Byford S; Potts L; Heslin M; Grey N; Turkington D; Fowler D; Kuipers E; Morrison A
    Trials; 2022 May; 23(1):429. PubMed ID: 35606886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE).
    Freeman D; Lister R; Waite F; Yu LM; Slater M; Dunn G; Clark D
    Trials; 2019 Jan; 20(1):87. PubMed ID: 30696471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active therapeutic processes of acceptance and commitment therapy for persistent symptoms of psychosis: clients' perspectives.
    Bacon T; Farhall J; Fossey E
    Behav Cogn Psychother; 2014 Jul; 42(4):402-20. PubMed ID: 23517883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial.
    Myin-Germeys I; van Aubel E; Vaessen T; Steinhart H; Klippel A; Lafit G; Viechtbauer W; Batink T; van Winkel R; van der Gaag M; van Amelsvoort T; Marcelis M; Schirmbeck F; de Haan L; Reininghaus U
    Psychother Psychosom; 2022; 91(6):411-423. PubMed ID: 35306502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial.
    Berkhof M; van der Stouwe ECD; Lestestuiver B; Van't Hag E; van Grunsven R; de Jager J; Kooijmans E; Zandee CER; Staring ABP; Pot-Kolder RMCA; Vos M; Veling W
    BMC Psychiatry; 2021 Oct; 21(1):496. PubMed ID: 34635063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial.
    Smith LC; Mariegaard L; Vernal DL; Christensen AG; Albert N; Thomas N; Hjorthøj C; Glenthøj LB; Nordentoft M
    Trials; 2022 Sep; 23(1):773. PubMed ID: 36100943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial.
    Barbeito S; Vega P; Ruiz de Azua S; Balanza-Martinez V; Colom F; Lorente E; Luengo A; Cerrillo E; Crespo JM; González Pinto A
    Trials; 2014 Oct; 15():416. PubMed ID: 25348346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialised early intervention teams for recent-onset psychosis.
    Puntis S; Minichino A; De Crescenzo F; Cipriani A; Lennox B; Harrison R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013288. PubMed ID: 33135811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.